(Q44969928)

English

Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia

scientific article published in July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Tomonori Yamanishi

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kosaku Yasuda

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Takao Kamai

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Toshihiko Tsujii

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ryuji Sakakibara

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Tomoyuki Uchiyama

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ken-Ichiro Yoshida

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

501-509

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Transurethral holmium: YAG laser prostatectomy using a side-firing fiber for bladder outlet obstruction due to benign prostatic enlargement: urodynamic evaluation of surgical outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Phytotherapy in the treatment of benign prostatic hyperplasia: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2004.00844.X

21 January 2018

Identifiers

10.1111/J.1442-2042.2004.00844.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44969928&oldid=2059877722"